Temporary Extension of Eligibility for the NINDS F32 Award Due the COVID-19 Pandemic
Notice Number:
NOT-NS-21-059

Key Dates

Release Date:

April 29, 2021

Related Announcements

PAR-21-032 - NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The NINDS F32 (PAR-21-032 - NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)) is designed specifically to support postdoctoral fellows who are beginning their training period in a new laboratory or research environment. Applicants are only eligible to apply for the NINDS F32 either before beginning or within the first 12 months of joining the postdoctoral lab in which the fellowship will be active. Given this eligibility window, many applicants apply either before or within the first 3 months in the laboratory (~30% of applicants have been in the postdoctoral laboratory for less than 3 months).

Due to the impact of the COVID-19 pandemic on newly appointed postdoctoral fellows, NINDS will provide a 1-receipt cycle extension of eligibility to individuals who started in their new laboratory between February 1 and May 30 of 2020. Ordinarily, the last NINDS F32 due date for these individuals would have been February, 2021. With this extension, these individuals will now be eligible to apply for the June, 2021 due date.

Individuals who started in their postdoctoral positions before February 1, 2020 or after May 30, 2020 have no change in their original eligibility window for the NINDS F32.

Inquiries

Please direct all inquiries to:

Michael Tennekoon, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email:michael.tennekoon@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices